Monogram robot wins FDA OK; Vicarious hit by supplier woes [Yahoo! Finance]
Vicarious Surgical Inc. Class A (RBOT)
Company Research
Source: Yahoo! Finance
Robotic surgery's growing popularity has attracted startups pursuing segments of the market across numerous medical specialties. Here are the latest developments at two companies looking to make a difference in the field. Monogram Technologies received Food and Drug Administration 510(k) clearance for its mBôS TKA System for total knee replacements and will now work toward commercializing the system, the Austin, Texas-based company said Monday. Monogram aims initially to place the robot with surgeons who are key opinion leaders in strategic geographies as it establishes clinical experience and demonstrates the platform in real-world settings. It plans to integrate recent upgrades to the robot's cutting system and other enhancements into the cleared mBôs device over the coming months. CEO Benjamin Sexson told MedTech Dive in 2023 that Monogram's robot uses a personalized alignment approach that allows surgeons to make precise adjustments during procedures, leading to greater pat
Show less
Read more
Impact Snapshot
Event Time:
RBOT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RBOT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RBOT alerts
High impacting Vicarious Surgical Inc. Class A news events
Weekly update
A roundup of the hottest topics
RBOT
News
- Vicarious Surgical Announces Full Year 2026 Cash Burn Guidance [Yahoo! Finance]Yahoo! Finance
- Vicarious Surgical Announces Full Year 2026 Cash Burn GuidanceBusiness Wire
- Vicarious Surgical (NYSE:RBOT) had its "neutral" rating reaffirmed by analysts at BTIG Research.MarketBeat
- Vicarious Surgical Announces Reduction in 2025 Cash Burn OutlookBusiness Wire
- Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare ConferenceBusiness Wire
RBOT
Earnings
- 11/12/25 - Beat
RBOT
Analyst Actions
- 12/15/25 - BTIG Research
RBOT
Sec Filings
- 12/17/25 - Form 25-NSE
- 12/16/25 - Form 8-K
- 12/16/25 - Form DEF
- RBOT's page on the SEC website